Your browser doesn't support javascript.
loading
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
Behrens, Georg Mn; Cossmann, Anne; Stankov, Metodi V; Nehlmeier, Inga; Kempf, Amy; Hoffmann, Markus; Pöhlmann, Stefan.
  • Behrens GM; Department for Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany; German Center for Infection Research, Partner Site Hannover-Braunschweig, Hannover, Germany. Electronic address: behrens.georg@mh-hannover.de.
  • Cossmann A; Department for Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • Stankov MV; Department for Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • Nehlmeier I; Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.
  • Kempf A; Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.
  • Hoffmann M; Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.
  • Pöhlmann S; Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.
Lancet ; 398(10305): 1041-1042, 2021 09 18.
Article en En | MEDLINE | ID: mdl-34416198
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article